Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.14T
Market cap1.14T
Price-Earnings ratio
44.27
Price-Earnings ratio44.27
Dividend yield
0.53%
Dividend yield0.53%
Average volume
3.57M
Average volume3.57M
High today
$1,236.00
High today$1,236.00
Low today
$1,190.22
Low today$1,190.22
Open price
$1,224.92
Open price$1,224.92
Volume
1.31M
Volume1.31M
52 Week high
$1,238.00
52 Week high$1,238.00
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

With a market cap of 1.14T, Eli Lilly(LLY) trades at $1,210.20. The stock has a price-to-earnings ratio of 44.27 and currently yields dividends of 0.53%.

On 2026-06-30, Eli Lilly(LLY) stock moved within a range of $1,190.22 to $1,236.00. With shares now at $1,210.20, the stock is trading +1.7% above its intraday low and -2.1% below the session's peak.

Trading activity shows a volume of 1.31M, compared to an average daily volume of 3.57M.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,238.00 and a low of $623.78.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,238.00 and a low of $623.78.

LLY News

Nasdaq 35m
Broker Darlings of the Dow: Johnson & Johnson Ranks As a Top 15 Analyst Pick

A study of analyst recommendations at the major brokerages shows that Johnson & Johnson (Symbol: JNJ) is the #8 broker pick, on average, out of the 30 stocks ma...

Broker Darlings of the Dow: Johnson & Johnson Ranks As a Top 15 Analyst Pick
Investing.com 1h
Why is Eli Lilly stock sliding today? - Investing.com

...

Why is Eli Lilly stock sliding today? - Investing.com
24/7 Wall St. 3h
AI Is Transforming Drug Discovery. Here Is the Next Trillion-Dollar Biotech Opportunity

AI Is Transforming Drug Discovery. Here Is the Next Trillion-Dollar Biotech Opportunity By Rich Duprey Published Jun 30, 9:38AM EDT Quick Read AI cuts drug di...

AI Is Transforming Drug Discovery. Here Is the Next Trillion-Dollar Biotech Opportunity

Analyst ratings

84%

of 31 ratings
Buy
83.9%
Hold
9.7%
Sell
6.5%

More LLY News

TipRanks 7h
Innovent Biologics, Eli Lilly enters Verzen distribution and promotion agreement

Innovent Biologics (IVBXF) and Eli Lilly (LLY) jointly announced that they have entered into a distribution and promotion agreement regarding Lilly’s CDK4 & 6 i...

CNBC 8h
Medicare will start covering obesity drugs for the first time. Here's what patients should know

Key Points Starting Wednesday, eligible seniors with Medicare coverage can access GLP-1s for obesity with a copay of just $50 per month through a temporary prog...

Medicare will start covering obesity drugs for the first time. Here's what patients should know
Nasdaq 12h
Big Pharma Has a Case of Merger Mania

In this episode of Motley Fool Hidden Gems Investing, Motley Fool contributors Tyler Crowe, Matt Frankel, and Lou Whiteman take a dive into what’s driving the m...

Big Pharma Has a Case of Merger Mania
Simply Wall St 16h
Eli Lilly Signs BioArctic Deal To Pursue BrainTransporter Neurodegeneration Research

Eli Lilly (NYSE:LLY) has entered a research and collaboration agreement with BioArctic focused on neurodegenerative disease treatments. The partnership centers...

Eli Lilly Signs BioArctic Deal To Pursue BrainTransporter Neurodegeneration Research
TipRanks 21h
FDA to Expedite Review of Eli Lilly’s New Manufacturing Facilities

Eli Lilly (LLY) is one of the first companies to be selected for a U.S. Food and Drug Administration (FDA) pilot program that’s designed to accelerate reviews o...

TipRanks 22h
Eli Lilly, Regeneron among first selections for FDA PreCheck program, CNBC says

Eli Lilly (LLY), Regeneron (REGN), Amneal (AMRX), Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will parti...

CNBC 22h
Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities

Key Points Eli Lilly, Regeneron, Amneal, Cellares, Fujifilm Biotechnologies, Kriya Therapeutics and Kyowa Kirin are the first companies that will participate in...

Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.